Technology News and Research

RSS

Wako receives FDA 510(k) clearance for uTASWako i30 with AFP-L3 and DCP assays

Wako Diagnostics, a division of Wako Chemicals USA, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the uTASWako i30 instrument with alpha-fetoprotein L3 (AFP-L3) and des-gamma-carboxy prothrombin (DCP) in vitro diagnostic (IVD) tests in the USA.

2 Mar 2011

Viewpoints: GOP Govs. on Medicaid 'flexibility'; 'attack' on planned parenthood; following doctors' orders not so easy

Medicaid is bureaucratic and costly, and the stimulus and new federal health care law have made a bad problem even worse, shackling states with unrealistic mandates.

2 Mar 2011

Nanotechnology holds promise for developing surgical measures

A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may provide powerful new tools that could have a marked impact on the therapeutic and diagnostic measures available to surgeons.

2 Mar 2011

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

VaxInnate Corporation today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services, worth up to $196 million to fund the development of recombinant seasonal and pandemic flu vaccines.

1 Mar 2011

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients requiring insulin.

1 Mar 2011

IRX Therapeutics signs research collaboration agreement with world's leading pharma companies

IRX Therapeutics, a developer of immune therapies to make cancer treatments better, announced today it has signed a research collaboration agreement with one of the world's leading research-based pharmaceutical companies.

1 Mar 2011

Pfizer acquires King Pharmaceuticals

Pfizer Inc. today announced that it has combined operations with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition of King through the merger of its wholly owned subsidiary, Parker Tennessee Corp., with and into King. King is now a wholly owned subsidiary of Pfizer.

1 Mar 2011

Supporters of open letter say 'Patent Amendment Bill' misses the point

An open letter with signatories including AusBiotech, Medicines Australia, Research Australia, the Walter and Eliza Hall Institute of Medical Research and Foursight has been addressed to members of the Australian Parliament, urging them to reject the ‘Patent Amendment (Human Genes and Biological Materials) Bill 2010’ as it misses the point on patient access and research exemption.

1 Mar 2011

Combined diagnosis and treatment of tumors: photothermically activated ultrasound contrast agent

Diagnosis and treatment form the basis of modern medicine. Traditionally, they are two separate steps; however, it doesn’t have to be that way. The term “theranostic” refers to the combination of a diagnostic test with a specific treatment based on the result of the test. This integrated approach should be particularly helpful in providing more targeted treatment for cancer patients.

1 Mar 2011

Nanotechnology holds promise for developing surgical measures

1 Mar 2011

Tengion prices $31.4 million through private placement financing

Tengion, Inc., a leader in regenerative medicine, today announced that it has entered into definitive agreements with certain investors in connection with a PIPE financing transaction pursuant to registration exemptions under the Securities Act of 1933, as amended.

1 Mar 2011

QLT fourth quarter revenues decrease 7.3% to $10.0 million

QLT Inc. today reported financial results for the fourth quarter ended December 31, 2010 and full year 2010 as well as issued its guidance for 2011. Unless specified otherwise, all amounts are in U.S. dollars and in accordance with U.S. GAAP.

1 Mar 2011

U-M's SIVQ software-tool can pinpoint cell and tissue samples more accurately

Ulysses Balis, M.D., clicks a mouse to identify a helicopter in a satellite photo of Baghdad, Iraq. With another click, an algorithm that he and his team designed picks out three more choppers without highlighting any of the buildings, streets, trees or cars.

1 Mar 2011

AMGA releases comments on preliminary proposals for Stage 2 Meaningful Use objectives

The American Medical Group Association, a trade association representing multispecialty medical groups and other organized systems of care, today released its comments on a request for information from the Health Information Technology Policy Committee on its preliminary proposals for Stage 2 Meaningful Use objectives.

1 Mar 2011

Survey finds social networking sites associated with one in five divorces in the US

If you're single, Facebook and other social networking sites can help you meet that special someone. However, for those in even the healthiest of marriages, improper use can quickly devolve into a marital disaster.

1 Mar 2011

Axolotl's two EHR systems receive ONC-ATCB certification

Axolotl Corp. announced that two of its electronic health record systems - Axolotl EHR, version 7 and Elysium EMR Lite - have received Office of the National Coordinator for Health IT Authorized Testing and Certification Body 2011/2012 certifications in accordance with Eligible Provider certification criteria adopted by the U.S. Department of Health and Human Services.

1 Mar 2011

ADC announces RNAscope technology clinical study results for HPV-associated head and neck cancers

Advanced Cell Diagnostics, Inc. today announced the results of its clinical study utilizing RNAscope technology to detect human papillomavirus E6/E7 mRNA in routine clinical specimens of head and neck cancer.

From Advanced Cell Diagnostics 1 Mar 2011

Psychology thesis reveals work motivation greatly reduces stress in IT consultants

Information Technology consultants experience less stress when they carry out assignments in a working environment that motivates them. It also helps IT consultants experience less stress if they are able to manage their own work and if the demands placed on them in their work are reasonable. This is revealed in a psychology thesis from Gothenburg University, Sweden.

1 Mar 2011

Intercell reports EUR 255.2m net loss for full year 2010

Today Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company's development programs.

1 Mar 2011

Objet, Remedent partner to enhance 3D printing solutions for cosmetic dentistry

Remedent, a global leader in porcelain veneers and teeth whitening solutions for the cosmetic dental industry, announced today that it has teamed up with Objet Geometries, the innovation leader in 3D printing for rapid prototyping and additive manufacturing, to enhance the fabrication process for dental veneer try-ins and delivery guides using Objet's 3D printing solutions.

1 Mar 2011

Technology News and Research

Wako receives FDA 510(k) clearance for uTASWako i30 with AFP-L3 and DCP assays

Viewpoints: GOP Govs. on Medicaid 'flexibility'; 'attack' on planned parenthood; following doctors' orders not so easy

Nanotechnology holds promise for developing surgical measures

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

FDA clears Valeritas' V-Go Disposable Insulin Delivery Device for use with NovoLog

IRX Therapeutics signs research collaboration agreement with world's leading pharma companies

Pfizer acquires King Pharmaceuticals

Supporters of open letter say 'Patent Amendment Bill' misses the point

Combined diagnosis and treatment of tumors: photothermically activated ultrasound contrast agent

Nanotechnology holds promise for developing surgical measures

Tengion prices $31.4 million through private placement financing

QLT fourth quarter revenues decrease 7.3% to $10.0 million

U-M's SIVQ software-tool can pinpoint cell and tissue samples more accurately

AMGA releases comments on preliminary proposals for Stage 2 Meaningful Use objectives

Survey finds social networking sites associated with one in five divorces in the US

Axolotl's two EHR systems receive ONC-ATCB certification

ADC announces RNAscope technology clinical study results for HPV-associated head and neck cancers

Psychology thesis reveals work motivation greatly reduces stress in IT consultants

Intercell reports EUR 255.2m net loss for full year 2010

Objet, Remedent partner to enhance 3D printing solutions for cosmetic dentistry

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News